A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Yohimbine
Lithium carbonate
The serum concentration of Lithium carbonate can be increased when it is combined with Fimasartan.
Yohimbine
Lithium citrate
The serum concentration of Lithium citrate can be increased when it is combined with Fimasartan.
Yohimbine
Cyclopenthiazide
Cyclopenthiazide may increase the hypotensive and Electrolyte Disturbance activities of Fimasartan.
Yohimbine
Mebutizide
Mebutizide may increase the hypotensive and Electrolyte Disturbance activities of Fimasartan.
Yohimbine
Semuloparin
The risk or severity of hyperkalemia can be increased when Semuloparin is combined with Fimasartan.
Yohimbine
Drospirenone
The risk or severity of hyperkalemia can be increased when Fimasartan is combined with Drospirenone.
Paramethasone
Chenodeoxycholic acid
The metabolism of Artesunate can be decreased when combined with Chenodeoxycholic acid.
Paramethasone
Flunitrazepam
The metabolism of Artesunate can be decreased when combined with Flunitrazepam.
Paramethasone
Umifenovir
The metabolism of Artesunate can be decreased when combined with Umifenovir.
Paramethasone
Isavuconazole
The metabolism of Artesunate can be decreased when combined with Isavuconazole.
Paramethasone
Deferasirox
The metabolism of Artesunate can be decreased when combined with Deferasirox.
Paramethasone
Perphenazine enanthate
The risk or severity of QTc prolongation can be increased when Artesunate is combined with Perphenazine enanthate.
Paramethasone
Dixyrazine
The risk or severity of QTc prolongation can be increased when Artesunate is combined with Dixyrazine.
Paramethasone
Thiazinam
The risk or severity of QTc prolongation can be increased when Artesunate is combined with Thiazinam.
Paramethasone
Chlorproethazine
The risk or severity of QTc prolongation can be increased when Artesunate is combined with Chlorproethazine.
Paramethasone
Butaperazine
The risk or severity of QTc prolongation can be increased when Artesunate is combined with Butaperazine.
Paramethasone
Perazine
The risk or severity of QTc prolongation can be increased when Artesunate is combined with Perazine.
Paramethasone
Propiopromazine
The risk or severity of QTc prolongation can be increased when Artesunate is combined with Propiopromazine.
Paramethasone
Cyamemazine
The risk or severity of QTc prolongation can be increased when Artesunate is combined with Cyamemazine.
Paramethasone
BL-1020
The risk or severity of QTc prolongation can be increased when Artesunate is combined with BL-1020.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3